Cargando…
Determinants of magnesium sulphate use in women hospitalized at <29 weeks with severe or non-severe pre-eclampsia
OBJECTIVE: Magnesium sulphate is recommended by international guidelines to prevent eclampsia among women with pre-eclampsia, especially when it is severe, but fewer than 70% of such women receive magnesium sulphate. We aimed to identify variables that prompt Canadian physicians to administer magnes...
Autores principales: | De Silva, Dane A., Proctor, Lily, von Dadelszen, Peter, McCoach, Meghan, Lee, Tang, Magee, Laura A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741231/ https://www.ncbi.nlm.nih.gov/pubmed/29272274 http://dx.doi.org/10.1371/journal.pone.0189966 |
Ejemplares similares
-
Maternal outcomes of magnesium sulphate and diazepam use in women with severe
pre-eclampsia and eclampsia in Ethiopia
por: Kassie, Gizat M., et al.
Publicado: (2014) -
Treatment of Eclampsia with Magnesium Sulphate
por: Quddus, M. A.
Publicado: (1946) -
Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia
por: Okusanya, BO, et al.
Publicado: (2015) -
Factors affecting use of magnesium sulphate for pre‐eclampsia or eclampsia: a qualitative evidence synthesis
por: Eddy, KE, et al.
Publicado: (2021) -
MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada
por: De Silva, Dane A., et al.
Publicado: (2018)